Bausch Health Companies BHC
NYSE BHC
$6.16 -0.26 (-4.12%)
As of: Sep 9, 2026 · 3:59 PM EDT

Bausch Health Companies (BHC) Shares Outstanding (2009 - 2026)

Bausch Health Companies' (BHC) quarterly Shares Outstanding (Entity) came in at $373.9 million in Q2 2026, up 1.12% year-over-year from $369.7 million in Q2 2025, and little changed quarter-over-quarter from $373.5 million in Q1 2026.

Analysis

Bausch Health Companies (BHC) Shares Outstanding (2009 - 2026) Analysis & Trends

Bausch Health Companies has disclosed Shares Outstanding (Entity) across 18 years of filings, most recently posting $373.9 million for Q2 2026.

  • In Q2 2026, Shares Outstanding (Entity) rose 1.12% year-over-year to $373.9 million; the TTM figure through Jun 2026 stood at $373.9 million (up 1.12% YoY), while the FY2025 annual figure was $370.5 million, up 0.73% from the prior year.
  • Shares Outstanding (Entity) came in at $373.9 million for Q2 2026 at Bausch Health Companies, roughly flat from $373.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Entity) ranged from a high of $373.9 million in Q2 2026 to a low of $361.3 million in Q1 2022.
  • Average Shares Outstanding (Entity) over 5 years is $366.7 million, with a median of $366.8 million recorded in 2024.
  • Year-over-year, Shares Outstanding (Entity) grew 0.63% in 2023 and rose 1.12% in 2026.
  • Over 5 years, Shares Outstanding (Entity) stood at $361.9 million in 2022, then increased by 0.92% to $365.2 million in 2023, then grew by 0.71% to $367.8 million in 2024, then advanced by 0.73% to $370.5 million in 2025, then gained by 0.91% to $373.9 million in 2026.
  • Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $373.9 million in Q2 2026, $373.5 million in Q1 2026, and $370.5 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn 1.17 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn 1.16 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn 832.44 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn 319.20 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 375.00 Mn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn 289.73 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 21.16 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn 43.64 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn 34.55 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn - 259.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 375.00 Mn
Mar 31, 2026 372.80 Mn
Dec 31, 2025 370.90 Mn
Sep 30, 2025 371.30 Mn
Jun 30, 2025 370.90 Mn
Mar 31, 2025 369.60 Mn
Dec 31, 2024 368.00 Mn
Sep 30, 2024 368.40 Mn
Jun 30, 2024 367.90 Mn
Mar 31, 2024 366.80 Mn
Dec 31, 2023 364.90 Mn
Sep 30, 2023 365.40 Mn
Jun 30, 2023 364.80 Mn
Mar 31, 2023 363.30 Mn
Dec 31, 2022 362.00 Mn
Sep 30, 2022 362.50 Mn
Jun 30, 2022 362.20 Mn
Mar 31, 2022 360.80 Mn
Dec 31, 2021 358.90 Mn
Sep 30, 2021 359.60 Mn